tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GHRS Stock Latest News

Psychedelic: Exclusive talk with biotech company Enveric Biosciences
The FlyPsychedelic: Exclusive talk with biotech company Enveric Biosciences
2d ago
ATAI
CMND
GH Research initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
GH Research initiated with an Overweight at Cantor Fitzgerald
10d ago
GHRS
GH Research initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
GH Research initiated with an Overweight at Cantor Fitzgerald
10d ago
GHRS
GH Research PLC Raises $139.8 Million Through Share Offering
PremiumCompany Announcements
GH Research PLC Raises $139.8 Million Through Share Offering
16d ago
6K
GHRS
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
16d ago
ATAI
CMND
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
16d ago
ACHL
ANVS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
17d ago
ICU
ANVS
GH Research Secures $150 Million in Public Offering
Premium
Company Announcements
GH Research Secures $150 Million in Public Offering
18d ago
6K
GHRS
GH Research 10M share Secondary priced at $15.00
PremiumThe Fly
GH Research 10M share Secondary priced at $15.00
18d ago
GHRS
GH Research Initiates $150 Million Public Offering to Advance Depression Treatment
PremiumCompany Announcements
GH Research Initiates $150 Million Public Offering to Advance Depression Treatment
19d ago
6K
GHRS
GH Research Updates Risk Factors Amid Ongoing Challenges
PremiumCompany Announcements
GH Research Updates Risk Factors Amid Ongoing Challenges
19d ago
6K
GHRS
GH Research announces $150M ordinary shares offering
PremiumThe Fly
GH Research announces $150M ordinary shares offering
19d ago
GHRS
GH Research’s Promising Phase 2b Trial of GH001 Drives Buy Rating Amid Breakthrough Potential in Psychedelic TRD Treatment
PremiumRatingsGH Research’s Promising Phase 2b Trial of GH001 Drives Buy Rating Amid Breakthrough Potential in Psychedelic TRD Treatment
20d ago
GHRS
GH Research’s GH001 Shows Promising Results in TRD Phase 2b Trial
Premium
Company Announcements
GH Research’s GH001 Shows Promising Results in TRD Phase 2b Trial
20d ago
6K
GHRS
GH Research announces primary endpoint met in Phase 2b trial of GH001
Premium
The Fly
GH Research announces primary endpoint met in Phase 2b trial of GH001
20d ago
GHRS
GH Research to Update on Promising TRD Treatment Trial
PremiumCompany Announcements
GH Research to Update on Promising TRD Treatment Trial
22d ago
6K
GHRS
GH Research Achieves Key Milestones in Depression Trials and Prepares FDA Response
PremiumCompany Announcements
GH Research Achieves Key Milestones in Depression Trials and Prepares FDA Response
1M ago
6K
GHRS
GH Research sees top-line data from Phase 2b trial in TRD in Q1
PremiumThe Fly
GH Research sees top-line data from Phase 2b trial in TRD in Q1
1M ago
GHRS
GH Research announces primary endpoint met in two Phase 2a PoC trials
PremiumThe Fly
GH Research announces primary endpoint met in two Phase 2a PoC trials
1M ago
GHRS
GH Research says completed all FDA requests to address IND hold
PremiumThe FlyGH Research says completed all FDA requests to address IND hold
1M ago
GHRS
GH Research PLC Attends Key Neuropsychopharmacology Conference
Premium
Company Announcements
GH Research PLC Attends Key Neuropsychopharmacology Conference
3M ago
6K
GHRS
GH Research Q3 2024 Results and Clinical Updates
Premium
Company Announcements
GH Research Q3 2024 Results and Clinical Updates
3M ago
GHRS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >